LAULETTA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 5.595
AS - Asia 2.202
EU - Europa 1.442
SA - Sud America 507
AF - Africa 80
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.829
Nazione #
US - Stati Uniti d'America 5.490
SG - Singapore 976
CN - Cina 543
BR - Brasile 409
SE - Svezia 311
HK - Hong Kong 235
IT - Italia 207
RU - Federazione Russa 193
DE - Germania 164
FI - Finlandia 113
UA - Ucraina 113
VN - Vietnam 106
FR - Francia 105
GB - Regno Unito 101
IN - India 74
CA - Canada 54
BD - Bangladesh 51
AR - Argentina 40
TR - Turchia 35
MX - Messico 32
ID - Indonesia 30
IQ - Iraq 23
JP - Giappone 23
PL - Polonia 22
BE - Belgio 20
ES - Italia 20
ZA - Sudafrica 18
NL - Olanda 17
PK - Pakistan 17
CI - Costa d'Avorio 15
CO - Colombia 15
IE - Irlanda 15
MA - Marocco 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
AT - Austria 11
PH - Filippine 11
VE - Venezuela 11
JO - Giordania 8
LT - Lituania 8
MY - Malesia 8
CZ - Repubblica Ceca 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
BO - Bolivia 6
EC - Ecuador 6
EG - Egitto 6
AZ - Azerbaigian 5
CL - Cile 5
PA - Panama 5
BH - Bahrain 4
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
NI - Nicaragua 4
UY - Uruguay 4
DZ - Algeria 3
JM - Giamaica 3
KR - Corea 3
MU - Mauritius 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
LY - Libia 2
OM - Oman 2
PE - Perù 2
TH - Thailandia 2
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 9.829
Città #
Fairfield 623
Ashburn 571
Singapore 535
San Jose 416
Chandler 414
Woodbridge 391
Seattle 255
Cambridge 252
Jacksonville 245
Houston 240
Nyköping 238
Hong Kong 234
Beijing 195
Wilmington 189
Ann Arbor 172
New York 98
Lauterbourg 80
Roxbury 76
Lawrence 73
Los Angeles 71
Nanjing 70
Dallas 66
Santa Clara 58
Boardman 53
Des Moines 53
Bari 50
Helsinki 46
Princeton 46
Brooklyn 45
Munich 38
Inglewood 37
São Paulo 33
San Diego 29
Buffalo 26
Ho Chi Minh City 25
Nanchang 24
Hebei 23
Tokyo 23
London 22
Brussels 20
Dong Ket 20
Shenyang 20
Toronto 20
Hanoi 19
Montreal 19
Council Bluffs 18
Jakarta 18
Denver 16
Falkenstein 16
Warsaw 16
Abidjan 15
Jiaxing 15
Dublin 14
Pune 14
Tianjin 14
Frankfurt am Main 13
Orem 13
San Francisco 13
Ankara 12
Belo Horizonte 12
Boston 12
Moscow 12
Phoenix 12
Tashkent 12
Changsha 11
Chicago 11
Columbus 11
Atlanta 10
Guangzhou 10
Jinan 10
Milan 10
Rome 10
Stockholm 10
The Dalles 10
Chennai 9
Grafing 9
Nuremberg 9
Paris 9
Amman 8
Baghdad 8
Charlotte 8
Guarulhos 8
Ostuni 8
Poplar 8
Shanghai 8
Casablanca 7
Haiphong 7
Johannesburg 7
Rio de Janeiro 7
Amsterdam 6
Brno 6
Curitiba 6
Dearborn 6
Elk Grove Village 6
Falls Church 6
Hounslow 6
Jeddah 6
Kuala Lumpur 6
Manaus 6
Medellín 6
Totale 6.809
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 219
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 206
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 199
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 193
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 192
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 191
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 190
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 175
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 158
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 156
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 155
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 151
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 150
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 148
Hepatitis C virus infection and mixed cryoglobulinemia 147
B-cell depletion in the treatment of mixed cryoglobulinemia. 145
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 145
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 144
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 139
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 134
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 134
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 134
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 133
Barrett's esophagus and esophageal cancer: An overview. 132
H. pylori infection and gastric cancer: state of the art (review). 128
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 127
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 126
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 124
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 122
null 122
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 121
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 118
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 118
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 115
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 115
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 114
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 113
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 112
A Challenging Case of Visceral Leishmaniasis 111
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 111
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 110
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 109
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 108
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 106
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 103
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 102
Crioglobulinemia mista e infezione da HCV 102
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 101
Cryoglobulinemic Vasculitis 101
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 101
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 100
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 97
null 96
Alcolizzazione percutanea del piccolo HCC. Casistica personale 95
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 94
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 93
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 92
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 92
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 91
Vasculiti primarie sistemiche 88
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 87
In reply. Transarterial chemoembolization plus sorafenib... 84
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 84
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 81
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 81
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 81
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 79
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 79
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 78
null 78
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 76
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 74
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 73
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 71
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 70
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 67
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 67
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 67
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 65
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 64
La vasculite crioglobulinemica: aspetti clinico-patogenetici 64
null 61
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 60
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 58
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study 56
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 55
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review 54
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 52
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 51
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 49
null 47
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 45
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 44
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 44
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 41
Terapia della sindrome crioglobulinemica 33
Totale 10.068
Categoria #
all - tutte 42.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/2022661 48 89 9 23 26 55 28 29 41 52 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024380 33 77 16 25 34 93 20 19 4 8 4 47
2024/20251.595 35 25 131 44 31 147 200 140 58 79 235 470
2025/20263.115 475 158 156 331 401 196 436 80 435 277 146 24
Totale 10.068